Hasil Pencarian - George Ansstas

Perbaiki Hasil
  1. 1
    Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series

    Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series oleh George Ansstas, David D. Tran

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    553 Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma

    553 Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma oleh George Ansstas, Renee Morecroft, Jordan Phillipps

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma

    BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma oleh Karam Khaddour, Tanner M Johanns, George Ansstas

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions

    The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions oleh Karam Khaddour, Tanner M. Johanns, George Ansstas

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma

    Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma oleh Karam Khaddour, Alice Zhou, Omar Butt, Jiayi Huang, George Ansstas

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies?

    Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies? oleh George Nassief, Angela Anaeme, Karen Moussa, David Chen, George Ansstas

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa

    Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa oleh Karam Khaddour, Emily S. Gorell, Farrokh Dehdashti, Jean Y. Tang, George Ansstas

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutation

    Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutation oleh Karam Khaddour, Ryan C. Fields, Michael Ansstas, Ilana S. Rosman, George Ansstas

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Recent Advancements in Cell-Based Therapies in Melanoma

    Recent Advancements in Cell-Based Therapies in Melanoma oleh George Nassief, Angela Anaeme, Karen Moussa, Abdallah N. Mansour, George Ansstas

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma

    Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma oleh Renee Morecroft, Jordan Phillipps, Alice Zhou, Omar Butt, Karam Khaddour, Tanner Johanns, George Ansstas

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome

    Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome oleh Karam Khaddour, Amy Musiek, Lynn A. Cornelius, Farrokh Dehdashti, Peter Westervelt, Ryan Fields, George Ansstas

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma

    180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma oleh Ari VanderWalde, Andrew Elliott, George Ansstas, Soo Park, Kevin Kim, George P Souroullas, Tolulope Adeyelu

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios

    Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios oleh Karam Khaddour, Karam Khaddour, Alice Zhou, Omar H. Butt, Griffin Budde, Allyson Koyen Malashevich, George Ansstas

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification

    Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification oleh George Nassief, BA, Omar H. Butt, MD, PhD, Alice Y. Zhou, MD, PhD, George Ansstas, MD

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Homologous Recombination Deficiency (HRD) in Cutaneous Oncology

    Homologous Recombination Deficiency (HRD) in Cutaneous Oncology oleh Favour A. Akinjiyan, Renee Morecroft, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Soo J. Park, Omar H. Butt, Alice Y. Zhou, George Ansstas

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma

    Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma oleh Jordan Phillipps, George Nassief, Renee Morecroft, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Ari Vanderwalde, Soo Park, Omar Butt, Alice Zhou, George Ansstas

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Objective response to immune checkpoint inhibitor therapy in NRAS-mutant melanoma: A systematic review and meta-analysis

    Objective response to immune checkpoint inhibitor therapy in NRAS-mutant melanoma: A systematic review and meta-analysis oleh Zachary J. Jaeger, Neel S. Raval, Natalia K. A. Maverakis, David Y. Chen, David Y. Chen, George Ansstas, Angela Hardi, Lynn A. Cornelius, Lynn A. Cornelius

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes

    ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes oleh Favour A. Akinjiyan, George Nassief, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Alice Y. Zhou, George Souroullas, Kevin B. Kim, Ari Vanderwalde, Soo J. Park, George Ansstas

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    BRAF mutations may identify a clinically distinct subset of glioblastoma

    BRAF mutations may identify a clinically distinct subset of glioblastoma oleh Samantha N. McNulty, Katherine E. Schwetye, Cole Ferguson, Chad E. Storer, George Ansstas, Albert H. Kim, David H. Gutmann, Joshua B. Rubin, Richard D. Head, Sonika Dahiya

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Durable melanoma control following disseminated talimogene laherparepvec herpetic infection

    Durable melanoma control following disseminated talimogene laherparepvec herpetic infection oleh Leonid Shmuylovich, MD, PhD, Aubriana M. McEvoy, MD, MS, Ryan C. Fields, MD, Leonel Hernandez-Aya, MD, George Ansstas, MD, David Y. Chen, MD, PhD

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: